Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study.

Autor: Romero-Laorden N; Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain; Cátedra UAM-Fundación Instituto Roche de Medicina Personalizada de Precisión, Madrid, Spain., Lorente D; Medical Oncology Department, Hospital Provincial de Castellón, Castellón de la Plana, Spain., de Velasco G; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Biomarkers in Genito-Urinary Cancers Group, I+12 Biomedical Research Institute, Madrid, Spain., Lozano R; Medical Oncology Department, Hospital Universitario de Salamanca, Salamanca, Spain., Herrera B; Urology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain; Genitourinary Cancers Traslational Research Unit, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain., Puente J; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain., López PP; Genomics and Therapeutics in Prostate Cancer Group, I+12 Biomedical Research Institute, Madrid, Spain., Medina A; Fundación Centro Oncológico de Galicia, A Coruña, Spain., Almagro E; Hospital Universitario Quirón, Pozuelo de Alarcón, Spain., Gonzalez-Billalabeitia E; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Biomarkers in Genito-Urinary Cancers Group, I+12 Biomedical Research Institute, Madrid, Spain., Villla-Guzman JC; Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., González-Del-Alba A; Department of Medical Oncology, Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain., Borrega P; Hospital San Pedro de Alcántara, Cáceres, Spain., Laínez N; Department of Medical Oncology, Navarra University Hospital, Pamplona, Spain., Fernández-Freire A; Hospital Universitario Torrecárdenas, Almería, Spain., Hernández A; Medical Oncology Department, Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastián, Spain., Rodriguez-Vida A; Medical Oncology Department, Hospital del Mar, CIBERONC, IMIM Research Institute, Barcelona, Spain., Chirivella I; Medical Oncology Department, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain., Fernandez-Parra E; Hospital Universitario de Valme, Sevilla, Spain., López-Campos F; Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Isabel Pacheco M; Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain., Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain., Fernández O; Medical Oncology Department, Complexo Hospitalario Universitario de Ourense, Ourense, Spain., Villatoro R; Hospital Universitario Costa del Sol, Marbella, Spain., Luque R; Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria ibs.Granada, Granada, Spain., Hernando S; Fundación Hospital Alcorcón, Alcorcón, Spain., Castellano DC; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Biomarkers in Genito-Urinary Cancers Group, I+12 Biomedical Research Institute, Madrid, Spain., Castro E; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Translational Cancer Genetics Group, I+12 Biomedical Research Institute, Madrid, Spain., Olmos D; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Genomics and Therapeutics in Prostate Cancer Group, I+12 Biomedical Research Institute, Madrid, Spain. Electronic address: dolmos.imas12@h12o.es.

Publikováno v: European urology oncology [Eur Urol Oncol] 2024 Jun; Vol. 7 (3), pp. 447-455. Date of Electronic Publication: 2023 Oct 12.